BioSymetrics

BioSymetrics is a phenomics-driven drug discovery company that integrates clinical and experimental data, using machine learning, to translate human disease biology and advance precision medicines. We partner with leading healthcare and life science companies, such as Northwell Health, Janssen, Sema4, and Mt. Sinai, to increase our understanding of disease and find better drugs faster. We use a patent pending, machine learning technology called Contingent-AITM to address bias detection and correction during pre-processing stages of machine learning and identify additional feature sets for analysis that are contingent upon decisions made during bias reduction. We combine this technology with an experimental practice...

Big data,machine learning,data science,computational biology,biomedical informatics,healthcare,software engineering,technology,artificial intelligence,biomedicine,medicine,digital health,pharmaceuticals,and drugdiscovery

Biosymetrics operates in the Biotechnology industry.

Biosymetrics's revenue is 1m - 10m

Biosymetrics has 11 - 50 employees.